Revolution Medicines Inc (RVMD)
Healthcare
Biotechnology
187.50 $
-2.4%
vs. previous close
Closing price · As of: 31. Jul 2026
Revolution Medicines Inc (RVMD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -898 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| -25 | 1.2 | -50 | -100 | -147 | -224 | -351 | -557 | -898 | |
| 1.2 | 1.8 | 3.3 | 6.5 | 7.3 | 9.7 | 9.3 | 12 | -27 | |
| 0.1 | 0.9 | 3.2 | 8.9 | 21 | 31 | 62 | 79 | 118 | |
| 0.1 | 3.2 | 3.5 | 8.5 | 24 | 28 | – | – | – | |
| 4.7 | 38 | -4.5 | -8.3 | 8.7 | -13 | 41 | 1.2 | 87 | |
| 1.6 | 1.5 | 2.6 | 2.9 | 6.5 | 11 | 7.7 | 10 | 16 | |
| -1.6 | -1.3 | -102 | -234 | -142 | -24 | -343 | -554 | 118 | |
| 23 | -0.1 | 0.0 | 0.8 | 1.9 | 1.9 | 3.3 | 5.0 | 8.0 | |
| 23 | 61 | 99 | 423 | 294 | 301 | 1,229 | 959 | 622 | |
| -4.1 | 61 | -53 | 88 | 4.9 | 53 | 535 | -153 | -158 | |
| -27 | -0.3 | -52 | -103 | -154 | -235 | -358 | -568 | -914 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.